Crossmark Global Holdings’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-11,300
Closed -$452K 1279
2024
Q2
$452K Buy
11,300
+275
+2% +$11.4K 0.01% 879
2024
Q1
$484K Sell
11,025
-194
-2% -$10K 0.01% 882
2023
Q4
$694K Sell
11,219
-194
-2% -$10.2K 0.01% 719
2023
Q3
$548K Buy
11,413
+168
+1% +$9.16K 0.01% 784
2023
Q2
$684K Sell
11,245
-259
-2% -$11.5K 0.01% 714
2023
Q1
$432K Sell
11,504
-107
-0.9% -$3.51K 0.01% 892
2022
Q4
$325K Buy
11,611
+330
+3% +$9.58K 0.01% 986
2022
Q3
$317K Buy
11,281
+129
+1% +$4.21K 0.01% 968
2022
Q2
$387K Buy
+11,152
New +$398K 0.01% 924

Other funds holding AMPH